Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H32N6O4S |
| Molecular Weight | 488.603 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=NN(C)C2=C1NC(=NC2=O)C3=CC(=CC=C3OCC)S(=O)(=O)N4C[C@H](C)N[C@H](C)C4
InChI
InChIKey=NFSWSZIPXJAYLR-GASCZTMLSA-N
InChI=1S/C23H32N6O4S/c1-6-8-18-20-21(28(5)27-18)23(30)26-22(25-20)17-11-16(9-10-19(17)33-7-2)34(31,32)29-12-14(3)24-15(4)13-29/h9-11,14-15,24H,6-8,12-13H2,1-5H3,(H,25,26,30)/t14-,15+
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Aildenafil citrate: a new potent and highly selective phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction]. | 2006 Dec |
|
| Liquid chromatography tandem mass spectrometry assay to determine the pharmacokinetics of aildenafil in human plasma. | 2007 May 9 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Aildenafil
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1416130-63-6
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
135452876
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
PRIMARY | |||
|
9T49W8GAX6
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
PRIMARY | |||
|
496835-35-9
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
PRIMARY | |||
|
DTXSID10197970
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
PRIMARY | |||
|
AILDENAFIL
Created by
admin on Sat Dec 16 07:59:11 GMT 2023 , Edited by admin on Sat Dec 16 07:59:11 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)
